These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23207695)

  • 1. Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing.
    Kaufmann KB; Brendel C; Suerth JD; Mueller-Kuller U; Chen-Wichmann L; Schwäble J; Pahujani S; Kunkel H; Schambach A; Baum C; Grez M
    Mol Ther; 2013 Mar; 21(3):648-61. PubMed ID: 23207695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells.
    Santilli G; Almarza E; Brendel C; Choi U; Beilin C; Blundell MP; Haria S; Parsley KL; Kinnon C; Malech HL; Bueren JA; Grez M; Thrasher AJ
    Mol Ther; 2011 Jan; 19(1):122-32. PubMed ID: 20978475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.
    Roesler J; Brenner S; Bukovsky AA; Whiting-Theobald N; Dull T; Kelly M; Civin CI; Malech HL
    Blood; 2002 Dec; 100(13):4381-90. PubMed ID: 12393624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simian immunodeficiency virus lentivector corrects human X-linked chronic granulomatous disease in the NOD/SCID mouse xenograft.
    Naumann N; De Ravin SS; Choi U; Moayeri M; Whiting-Theobald N; Linton GF; Ikeda Y; Malech HL
    Gene Ther; 2007 Nov; 14(21):1513-24. PubMed ID: 17728796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy.
    Brendel C; Hänseler W; Wohlgensinger V; Bianchi M; Tokmak S; Chen-Wichmann L; Kuzmenko E; Cesarovic N; Nicholls F; Reichenbach J; Seger R; Grez M; Siler U
    Hum Gene Ther Methods; 2013 Jun; 24(3):151-9. PubMed ID: 23489116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity.
    Suerth JD; Maetzig T; Brugman MH; Heinz N; Appelt JU; Kaufmann KB; Schmidt M; Grez M; Modlich U; Baum C; Schambach A
    Mol Ther; 2012 May; 20(5):1022-32. PubMed ID: 22334016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis.
    Chiriaco M; Farinelli G; Capo V; Zonari E; Scaramuzza S; Di Matteo G; Sergi LS; Migliavacca M; Hernandez RJ; Bombelli F; Giorda E; Kajaste-Rudnitski A; Trono D; Grez M; Rossi P; Finocchi A; Naldini L; Gentner B; Aiuti A
    Mol Ther; 2014 Aug; 22(8):1472-1483. PubMed ID: 24869932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous disease.
    Stein S; Scholz S; Schwäble J; Sadat MA; Modlich U; Schultze-Strasser S; Diaz M; Chen-Wichmann L; Müller-Kuller U; Brendel C; Fronza R; Kaufmann KB; Naundorf S; Pech NK; Travers JB; Matute JD; Presson RG; Sandusky GE; Kunkel H; Rudolf E; Dillmann A; von Kalle C; Kühlcke K; Baum C; Schambach A; Dinauer MC; Schmidt M; Grez M
    Hum Gene Ther Clin Dev; 2013 Jun; 24(2):86-98. PubMed ID: 23845071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.
    Kang EM; Choi U; Theobald N; Linton G; Long Priel DA; Kuhns D; Malech HL
    Blood; 2010 Jan; 115(4):783-91. PubMed ID: 19965657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/beta -microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells.
    Brenner S; Whiting-Theobald NL; Linton GF; Holmes KL; Anderson-Cohen M; Kelly PF; Vanin EF; Pilon AM; Bodine DM; Horwitz ME; Malech HL
    Blood; 2003 Oct; 102(8):2789-97. PubMed ID: 12829597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease.
    Dinauer MC; Li LL; Björgvinsdóttir H; Ding C; Pech N
    Blood; 1999 Aug; 94(3):914-22. PubMed ID: 10419882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells.
    Moreno-Carranza B; Gentsch M; Stein S; Schambach A; Santilli G; Rudolf E; Ryser MF; Haria S; Thrasher AJ; Baum C; Brenner S; Grez M
    Gene Ther; 2009 Jan; 16(1):111-8. PubMed ID: 18784749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy of chronic granulomatous disease.
    Grez M; Becker S; Saulnier S; Knöss H; Ott MG; Maurer A; Dinauer MC; Hoelzer D; Seger R; Hossle JP
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S99-104. PubMed ID: 10933200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation.
    Sadat MA; Dirscherl S; Sastry L; Dantzer J; Pech N; Griffin S; Hawkins T; Zhao Y; Barese CN; Cross S; Orazi A; An C; Goebel WS; Yoder MC; Li X; Grez M; Cornetta K; Mooney SD; Dinauer MC
    Gene Ther; 2009 Dec; 16(12):1452-64. PubMed ID: 19657370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells.
    Becker S; Wasser S; Hauses M; Hossle JP; Ott MG; Dinauer MC; Ganser A; Hoelzer D; Seger R; Grez M
    Hum Gene Ther; 1998 Jul; 9(11):1561-70. PubMed ID: 9694155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease.
    Björgvinsdóttir H; Ding C; Pech N; Gifford MA; Li LL; Dinauer MC
    Blood; 1997 Jan; 89(1):41-8. PubMed ID: 8978275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bicistronic retrovirus vector containing a picornavirus internal ribosome entry site allows for correction of X-linked CGD by selection for MDR1 expression.
    Sokolic RA; Sekhsaria S; Sugimoto Y; Whiting-Theobald N; Linton GF; Li F; Gottesman MM; Malech HL
    Blood; 1996 Jan; 87(1):42-50. PubMed ID: 8547675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease.
    Brendel C; Rothe M; Santilli G; Charrier S; Stein S; Kunkel H; Abriss D; Müller-Kuller U; Gaspar B; Modlich U; Galy A; Schambach A; Thrasher AJ; Grez M
    Hum Gene Ther Clin Dev; 2018 Jun; 29(2):69-79. PubMed ID: 29664709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-level reconstitution of respiratory burst activity in a human X-linked chronic granulomatous disease (X-CGD) cell line and correction of murine X-CGD bone marrow cells by retroviral-mediated gene transfer of human gp91phox.
    Ding C; Kume A; Björgvinsdóttir H; Hawley RG; Pech N; Dinauer MC
    Blood; 1996 Sep; 88(5):1834-40. PubMed ID: 8781441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Repair of CYBB in X-CGD iPSCs Requires Retention of Intronic Sequences for Expression and Functional Correction.
    Sweeney CL; Zou J; Choi U; Merling RK; Liu A; Bodansky A; Burkett S; Kim JW; De Ravin SS; Malech HL
    Mol Ther; 2017 Feb; 25(2):321-330. PubMed ID: 28153086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.